How much does a box of Erlotinib cost? What is the latest price reference in 2025?

Erlotinib is an oral targeted therapy drug mainly used to treat patients with non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations. At present, the drug has been on the market in China for many years and has been successfully included in the national medical insurance directory, making it more convenient for patients to purchase it in domestic hospitals or pharmacies and enjoy the medical insurance reimbursement policy.

According tothe latest market information in 2025, the domestic price of erlotinib purchased through medical insurance channels has dropped significantly. After medical insurance reimbursement, the actual price paid by the patient is usually only a few hundred yuan, which greatly reduces the financial burden. Since medical insurance policies vary slightly in different regions, it is recommended that patients consult the local hospital pharmacy or medical insurance bureau for specific reimbursement ratios and co-pay amounts before purchasing medicines.

In foreign markets, erlotinib also has multiple versions, including original drugs and generic drugs. Although original drugs are guaranteed in terms of efficacy and quality, their prices are usually on the high side. The price of generic drugs from countries such as Laos is relatively close to the people. Judging from the current market conditions, a box of Laos version of erlotinib costs about 400 yuan, which is suitable for patients who need long-term medication but have limited financial conditions.

In general, erlotinib, as a mature targeted drug, has good accessibility and medical insurance support in China, and is an important treatment option for many patients with EGFR mutated lung cancer. When patients choose drug purchasing channels, they should consider factors such as price, reimbursement policy, and drug sources to ensure safe and standardized use of drugs.

Reference:https://en.wikipedia.org/wiki/Erlotinib